Ironwood Pharmaceuticals director Andrew Dreyfus resigns effective Nov 1, 2025

IRONWOOD PHARMACEUTICALS INC

Andrew Dreyfus resigned from the Board, effective November 1, 2025.
Resignation due to his appointment as President and CEO of NIHCM Foundation.
No disagreement with Ironwood's operations, policies, or practices.
Company expressed gratitude for his service on the Board.

item 5.02

IRONWOOD PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001104659-25-098523

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.